Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies
The epidemiology of head and neck squamous cell carcinoma (HNSCC) has shifted dramatically over the last 50 years, as smoking-related HNSCCs decrease in incidence while human papillomavirus (HPV)-related cancers rise. The shift in HNSCC risk factors has changed patient demographics, the distribution of affected anatomical subsites, and prognosis of this illness. As such, the medical community has responded by devising novel staging systems and prevention strategies. The medical community will require continued vigilance in reducing HNSCC traditional risks factors for HNSCC, such as cigarette use, and emerging risk like HPV infection.
KeywordsHead and neck squamous cell carcinoma Human papillomavirus Epidemiology Head and neck cancer
Compliance With Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48 A large comprehensive assessment of the global burden of cancers, including HNSCC.Google Scholar
- 3.• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30 The yearly evaluation of cancer burden in the USA.Google Scholar
- 9.Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99(10):777–89.PubMedGoogle Scholar
- 18.• Voltzke KJ, Lee YA, Zhang ZF, Zevallos JP, Yu GP, Winn DM, et al. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Cancer Causes Control. 2018. Updated analysis of risk factors for head and neck squamous cell carcinoma;29:619–30.PubMedGoogle Scholar
- 20.•• O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–51 A large, multi-center study used to create the 8th edition TNM staging system for oropharynx cancer.Google Scholar
- 35.Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomark Prev. 1995;4(4):415–28.Google Scholar
- 37.Trottier H, Mayrand MH, Coutlee F, Monnier P, Laporte L, Niyibizi J, et al. Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: design, methods and preliminary results of the HERITAGE study. Papillomavirus Res. 2016;2:145–52.PubMedPubMedCentralGoogle Scholar
- 43.Rettig EM, Zaidi M, Faraji F, Eisele DW, El Asmar M, Fung N, et al. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: analysis of the National Cancer Database. Oral Oncol. 2018;83:147–53.PubMedGoogle Scholar
- 51.Negri E, La Vecchia C, Franceschi S, Tavani A. Attributable risk for oral cancer in northern Italy. Cancer Epidemiol Biomark Prev. 1993;2(3):189–93.Google Scholar
- 52.Kim L, King T, Agulnik M. Head and neck cancer: changing epidemiology and public health implications. Oncology (Williston Park). 2010;24(10):915–24.Google Scholar
- 62.•• Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, et al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol. 2016;62:11–9 A large multicenter study used to establish the surgical TNM staging for 8th edition.PubMedPubMedCentralGoogle Scholar
- 63.Amin MB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. Eight edition / editor-in-chief, Mahul B. Amin, MD, FCAP ; editors, Stephen B. Edge, MD, FACS and 16 others ; Donna M. Gress, RHIT, CTR - Technical editor ; Laura R. Meyer, CAPM - Managing editor. ed. Chicago IL: American Joint Committee on Cancer, Springer; 2017. xvii, 1024 pages p.Google Scholar
- 69.Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):89–99.PubMedGoogle Scholar
- 75.FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old [Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.htm.
- 76.Human papillomavirus (HPV) vaccination coverage in adolescent females in England: 2016/17 [Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/666087/HPV_vaccination_coverage_in_adolescent_females_in_England_2016_to_2017.pdf.
- 77.National (Australia) HPV 3 dose vaccination coverage for adolescents turning 15 years of age [Available from: http://www.hpvregister.org.au/research/coverage-data. Accessed 4 Apr 2019.
- 78.Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136(12):2752–60.PubMedGoogle Scholar
- 80.Primack BA, Shensa A, Sidani JE, Hoffman BL, Soneji S, Sargent JD, et al. Initiation of traditional cigarette smoking after electronic cigarette use among tobacco-naive US young adults. Am J Med. 2018;131(4):443 e1–9.Google Scholar
- 84.FDA seeks tighter restrictions on E-cigarettes. Cancer Discov. 2019;9(1):OF3. https://doi.org/10.1158/2159-8290.CD-NB2018-158.